Understanding lymphoma trial results and progression-free survival data for better treatment decisions and quality of life.

Understanding lymphoma trial results and progression-free survival data for better treatment decisions and quality of life.







Understanding lymphoma trial results and progression-free survival data for better treatment decisions and quality of life.

Interstitial lung disease diagnosis is often delayed due to overlapping symptoms with asthma and heart failure, requiring physicians…

Retatrutide access opens as Eli Lilly launches a compassionate‑use program for patients unable to join clinical trials, awaiting…

Community doula partnership in Erie tackles food insecurity, housing instability, and maternal health gaps, delivering early results and…

Oncologists face insurance delays and logistical hurdles blocking access to advanced cancer treatments like CAR T-cell therapy.

Experts discuss barriers to obesity care access and explore policy solutions for ensuring consistent patient treatment options are…

Vitamin D deficiency linked to kidney disease affects bone health, blood pressure, immune function and survival, revealing a…

Pharmacy oncology is reshaping cancer care as Minnesota leaders tackle operational and financial hurdles to expand outpatient bispecific…

The multiple myeloma trial reveals an 89% lower risk of disease progression or death with the teclistamab‑talquetamab combo,…

CDC links thousands of Cyclospora outbreak cases to Taco Bell lettuce. Follow the latest updates on the foodborne…